Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics.
journal contribution
posted on 2014-05-01, 00:00authored byN Pritchard, K Edwards, C Dehghani, H Fadavi, M Jeziorska, A Marshall, I Petropoulos, G Ponirakis, A Russell, Geoff SampsonGeoff Sampson, A Shahidi, S Srinivasan, M Tavakoli, D Vagenas, R Malik, N Efron
Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics.